Publications by authors named "Mitchell B Lowenstein"

Claim this Profile
O
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Mark C Genovese, Jeffrey L Kaine, Mitchell B Lowenstein, José Del Giudice, Andrew Baldassare

Arthritis Rheum· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis